Page 210 - Pharmaceutics IV (02-06-01305)

by the dispensing pharmacist or nuclear pharmacy technician .There
is no patient treatment area .Imaging clinics (e.g. cardiology
,oncology , general nuclear ),purchase unit dose
radiopharmaceuticals from a commercial nuclear pharmacy.

Hospital nuclear pharmacies are separate from the hospital
pharmacy &are adjacent to nuclear medicine or radiology
departments. Usually doses are prepared in the hospital nuclear
pharmacy area & transported to the nuclear medicine department

For administration by a nurse or certified nuclear medicine
technologist in a treatment /administration room or private patient

area .The patient is then brought to the “camera room “ for imaging

To limit acute &chronic radiation exposure of inspecting personal to
a level that is as low as reasonably achievable ,direct visual
inspection of radiopharmaceutical CSPs containing high
concentrations of radioactivity .

Radiopharmaceuticals prepared as low risk level CSPs with 12 hr. or
less beyond the use date are to be prepared jn a segragated
compounding area .

Radiopharmaceuticals for PET compounding conform to the USP

Standards, compounding procedure verification & stability testing

& expiration dating are provided.

Quality control tests to be performed on individual batches
.Procedures are for PET labeled with a nuclide having a t1/2 > 20

Minutes& PET radiopharmaceuticals < 20 minutes .Each batch of
PET radiopharmaceutical intended for parenteral administration ,a
membrane filter integrity test is performed immediately after

20